NCT00393211View on ClinicalTrials.gov

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

PHASE3CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

November 30, 2000

Study Completion Date

November 30, 2000

Conditions
Recurrent Low Back Pain
Interventions
DRUG

MK0663, Etoricoxib / Duration of Treatment : 12 Weeks

DRUG

Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00393211 - Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042) | Biotech Hunter | Biotech Hunter